Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agustin Pappolla

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|September 13, 2024
MiRNA-based therapeutic potential in multiple sclerosisAna Zabalza, Agustin Pappolla, Manuel Comabella, et al.
The Neurologist|December 27, 2018
Bilateral Optic Perineuritis as Initial Presentation of Giant Cell ArteritisAgustin Pappolla, Facundo Silveira, Jorge Norscini, et al.
Neurology India|August 30, 2020
Rapidly Progressive Dementia as a Clinical Feature of Multiple Dural Arteriovenous FistulasAgustin Pappolla, Federico Sosa Albacete, Ariel Luzzi, et al.
Neurology India|November 8, 2021
Meningeal Involvement as Initial Presentation of Waldenström Macroglobulinemia (Bing-Neel Syndrome)Agustin Pappolla, Zurru Maria Cristina, Marcelo Rugiero, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 27, 2023
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment FailureSunny Malhotra, Laura Hurtado-Navarro, Agustin Pappolla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple SclerosisNicolás Fissolo, Agustin Pappolla, Jordi Rio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2025
Performance of treatment response scoring systems among patients with multiple sclerosis treated with high-efficacy therapiesMariano Marrodan, Augusto Sao Avilés, Jordi Río, et al.
Neurology|March 6, 2024
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseLuca Bollo, Georgina Arrambide, Alvaro Cobo-Calvo, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 29, 2024
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTsAgustin Pappolla, Cristina Auger, Augusto Sao-Aviles, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|September 13, 2024
MiRNA-based therapeutic potential in multiple sclerosisAna Zabalza, Agustin Pappolla, Manuel Comabella, et al.
The Neurologist|December 27, 2018
Bilateral Optic Perineuritis as Initial Presentation of Giant Cell ArteritisAgustin Pappolla, Facundo Silveira, Jorge Norscini, et al.
Neurology India|August 30, 2020
Rapidly Progressive Dementia as a Clinical Feature of Multiple Dural Arteriovenous FistulasAgustin Pappolla, Federico Sosa Albacete, Ariel Luzzi, et al.
Neurology India|November 8, 2021
Meningeal Involvement as Initial Presentation of Waldenström Macroglobulinemia (Bing-Neel Syndrome)Agustin Pappolla, Zurru Maria Cristina, Marcelo Rugiero, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 27, 2023
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment FailureSunny Malhotra, Laura Hurtado-Navarro, Agustin Pappolla, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple SclerosisNicolás Fissolo, Agustin Pappolla, Jordi Rio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2025
Performance of treatment response scoring systems among patients with multiple sclerosis treated with high-efficacy therapiesMariano Marrodan, Augusto Sao Avilés, Jordi Río, et al.
Neurology|March 6, 2024
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseLuca Bollo, Georgina Arrambide, Alvaro Cobo-Calvo, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 29, 2024
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTsAgustin Pappolla, Cristina Auger, Augusto Sao-Aviles, et al.
Pageof 2